心血管

医院简介

  • 中文版 Chinese
  • 英文版 English

泰达国际心血管病医院(简称泰心医院)是天津经济技术开发区投资兴建的、纳入中国医学科学院北京协和医学院管理体系的三级甲等心血管病专科医院和心血管研究所,与国家心血管病中心、中国医学科学院阜外医院和加拿大多伦多儿童医院建立了全面合作关系。是迄今国内唯一完成党中央、国务院新医改任务的公立医院,取消了行政级别和事业编制,实行全员聘用制、岗位管理和岗位绩效工资制度。被《求是》杂志称为“公立医院的先行者”。



医院总投资7.2亿元,建筑面积7.6万平米,设置病床500张,可开展从常规心血管手术到心脏移植在内的各类心血管外科手术和各类心血管内科介入手术。其心脏大血管外科、心血管内科和护理通过国家临床重点专科建设评估。泰心医院还是天津医科大学心血管病临床学院、国家冠心病和心律失常介入诊疗培训基地、国家住院医师规范化培训基地、国家医院消毒供应中心实践基地、国家首批心血管病专科护理及技术培训示范基地。有博士后工作站和院士专家工作站。


泰心医院四次通过美国国际医院评审标准(JCI)认证,心力衰竭、急性心肌梗死、冠状动脉搭桥术三个诊疗项目通过JCI临床诊疗项目(CCPC)认证,是国际首家通过冠状动脉搭桥术CCPC评审的医院;通过美国医疗信息与管理系统协会(HIMSS)7级认证,是美国以外全球第9家、国内第3家通过HIMSS7级评审的医院,也是我国第一家同时通过JCI和HIMSS7级认证的医院;检验科七次通过ISO15189认证;中心实验室四次通过美国病理家协会(CAP)认证。



自2003年建院伊始,医院在管理体制上:取消行政级别,实行管办分离、院长负责制;取消事业编制,实行全员聘任、岗位管理;取消档案工资管理体系,实行不与任何业务收入挂钩的岗位绩效工资制度等。在运行机制上:破除以药养医,在天津市三级医院范围内率先实行药品零差率,并实现按顿包药,收入的药占比仅为12%左右;在国内率先实施临床路径,规范诊疗和护理行为,使平均住院日逐年下降至5.3天;与医保实施按病种付费的结算方式;护理实行垂直管理和岗位分级管理;后勤服务完全实现社会化;推出免费为住院病人提供一日三餐和水果,免费为重症患者提供护工的惠民政策。



泰心医院以“博爱·济世”为院训,已为包括港澳台在内的全国所有省市区及美、德、加、俄、黎等国家的17万多名患者实施心脏手术和介入治疗,成功完成8例心脏移植和1例已存活13年的心肾联合移植;为来自27个省市区、27个少数民族13000余名孤贫儿童实施先心病根治手术;与天津市妇儿保健中心合作,在国内率先开展儿童先心病普查工作,筛查已超过120万余名儿童,使天津市成为我国唯一对儿童心脏发育状况进行“零网眼”普查的省级单位;从2011年起分别与中国移动慈善基金会、上海荷福慈善基金会、中国卫生法学会联手,先心病筛查车跑遍内蒙古、河南、辽宁、山西、青海、西藏、宁夏、甘肃、广西、江西、贵州、四川、安徽和河北等15个省和自治区开展先心病筛查,并对贫困先心病儿童展开救助工作;还开创我国跨省医保的先河,相继成为河北省唐山、廊坊、张家口、秦皇岛、承德、邯郸,内蒙古满洲里,黑龙江哈尔滨及辽河油田等地非转诊跨省医保定点医院,同时也是天津市唯一的医保创新实践基地;2017年1月与吉林省医保中心完成全国异地就医直接结算第一单;2019年6月成为全口径对接河北省的定点医院。


泰心医院科研工作也获得重大突破。2012年获得天津市自然科学奖一等奖,这是天津市设立此奖项来医药类第三个一等奖;2013年研发出的具有完全自主知识产权的磁液双悬浮第三代血泵,填补国内的空白,创造多项国内第一。2019年具有完全自主知识产权的“火箭心”——HeartCon心室辅助装置成功植入两名终末期扩张型心肌病患者体内,使之获得新生,该心室辅助装置具有唯一纯国资企业生产、唯一自始至终医工结合、唯一国内原创独立自主知识产权、唯一全套产品在国内研制的特点。



先进的管理体制产生简单而健康的人际关系,催生融洽而和谐的医院文化。这所既无红包、又无回扣的病人至上的医院开院十五年来所取得的成绩得到了社会的广泛认可,赢得了国内外宾客和业界的高度赞誉。李克强总理等多位国家和部委领导人先后到医院调研视察,认为“泰心医院发展方向是正确的、成效是显著的、经验是宝贵的,启发和借鉴是多方面的,值得向全国推广”。在国家统计局天津调查总队、市纪委驻卫生局纪检组、天津日报传媒集团调查研究中心和市卫生计生委开展的多次对全市41家三级医院患者综合满意度调查中,泰心医院满意率始终名列前茅。


泰心医院于2010年、2012年、2014年、2018年四次获得“天津市人民满意的好医院”称号,2012年荣获“全国卫生系统先进集体”称号;2017年、2018年连续荣获国家卫生计生委“进一步改善医疗服务行动”先进单位称号。新华社、中央电视台、中央人民广播电台、《人民日报》、《求是》杂志、《光明日报》、《经济日报》、《科技日报》、《健康报》及《大公报》、《华尔街日报》等中外新闻媒体均报道了医院的典型经验。



2019年9月


Chinese Academy of Medical Sciences Peking Union Medical College TEDA International Cardiovascular Hospital (TICH)/Tianjin Medical University Cardiovascular Institute, invested by Tianjin Economic-technologic Development Area Government, is a public nonprofit, top-class, professional cardiovascular hospital opened since Sept. 26, 2003. The hospital specializes in cardiovascular open-heart surgery and interventional therapy to cure all types of congenital or acquired cardiovascular diseases. There are 500 beds, 16 operation rooms, 80 ICU beds, 5 catheter lab rooms (including a hybrid operation room) and 40 CCU beds at TICH.



TICH is equipped with state-of-the-art equipment for diagnosis, treatment, and research, including PET/CT, “Diamond” CT, 64-slice CT, ECT, MRI, 3-D Echocardiography, MCG and high-power electronic microscope. It pioneers in the use of Automatic Tablet Counting and Packing machines in China which greatly improves efficiency and quality in the medication dispensing. The medical laboratory is equipped with an Automatic Clinical Laboratory System supported by Pre-Analytical Modular(PAM)for highly accurate diagnostic tests. The transferring system improves the efficiency of the delivery of documents and samples within the hospital. The advanced Picture Archiving and Commutation System (PACS) and Hospital Information System (HIS) make the hospital completely electronic and, significantly, literally paperless.


The departments of Cardiovascular Surgery, cardiology and nursing are entitled of national-level clinical specialties by the Ministry of Health of China. TICH is also one of National Coronary Disease Training Centers, National Arrhythmia Interventional Therapy Training Centers, National Residence Training Centers and China Chest Pain Centers. Internationally, TICH has been certified hospital accreditation and CCPC of AMI, HF and CABG by Joint Commission International (JCI). This international recognition makes it enjoy the first hospital in China to earn the international accreditation of cardiovascular disease treatment. Besides, the capability and facility of the hospital informatics infrastructure has reached HIMSS EMRAM 7.



TICH is the only public hospital consistent with National Healthcare Reform Plan announced by the State of Council. Since the very beginning, TICH management has been separated from its ownership. While the TEDA Government owns the hospital, President Xiaocheng Liu is responsible for its general management. As the only public hospital without official ranking, TICH recruits its staffs by signing employment contracts rather than utilizing the lifelong tenure model as is used in other public hospitals. TICH assigns staff posts according to the efficiency and effectiveness of the resulting management rather than the traditional “Official and Title” approach to management systems. The innovative management system has brought vitality to TICH and made the hospital create a series of operating mechanism reflecting patient-oriented concepts, which has won not only patients’ satisfaction but also much more space and faster speed for sustainable development.



Over the past 15 years since its opening, TICH has performed cardiac surgery and interventional cardiovascular procedure for more than 100,000 patients from all over China and the foreign countries. On one hand, the hospital adhering to humanitarianism provides reasonable and quality medical service to the communities. In August 2004, TICH became the first hospital designated by the Ministry of Civil Affairs of China to carry out a charity program, namely “Tomorrow Plan”, to help treat the orphans suffering congenital heart diseases. Thereafter, through joint efforts with many charity organizations from both home and abroad, more than 12,000 orphan and underprivileged children, from 27 provinces, municipalities and autonomous regions, have gained their new lives in TICH. On the other hand, diversified niche service is offered to those in need, including some Hollywood movie star and foreign national leader.


Congenital Heart Disease is NO. 1 killer to 0-5 group children in China. Together with Tianjin Women and Children Health Center, TICH launched the first congenital heart disease screening program in China in 2005. Up to date, there have been more than 1200,000 children screened in Tianjin and surprisingly 2.22% of them are positive. From 2010, hand in hand with China Mobile, TICH enlarged the congenital heart disease screening program to Inner Mongolia, Henan, Liaoning, Shanxi, Qinghai, Tibet, Guangxi, Jiangxi and Ningxia Provinces.



Three JCI golden medals, cardiovascular surgery, cardiology and nursing on the list of national clinic specialties, Tianjin Science & Technology first prize, the long-term survival experiment animal implanted with the third generation LVAD…….a string of footprints has been deeply marked in the course of its non-stop innovation and progress.


On November 15, 2010, Vice-Premier Li Keqiang visited TICH. He talked with patients, physicians, and nurses in the pharmacy and in the consultation rooms. Mr. Li confirmed wholeheartedly TICH’s manner of managing the hospital. He stated, “…TICH is in the leading position within the area of public hospital reform in China. In reforming our Public Hospital system, we seek not just to make the system as perfect as possible. We should take this opportunity to completely assess our system and diversify the investment and capital structures of hospitals. This will further provide better, more complete medical services to the Chinese people and enhance the skill of China’s medical staff.”


联系我们  Contact Information

门诊预约电话:022 - 65208888

网络服务热线:4001 - 568 - 568

地址:天津市经济技术开发区第三大街61号








 公有非营利   三级甲等心血管病专科医院



地址:天津市经济技术开发区第三大街61号
Address: 61,Third Avenue,TEDA,Tianjin,China
电话:022-65208888

(信产部ICP备案号:津ICP备06002205)本站版权归泰达国际心血管病医院所有,未经许可,谢绝一切转载。 技术支持:国家动漫园 影视制作中心